The impact of resveratrol on toxicity and related complications of advanced glycation end products: A systematic review

source extracted confidence: high 2026-04-09
#animals #antigens-neoplasm #antioxidants #atherosclerosis #diabetes-mellitus-experimental

The impact of resveratrol on toxicity and related complications of advanced glycation end products: A systematic review

Hajizadeh-Sharafabad et al., 2019 | Biofactors | Systematic Review

Citation

Hajizadeh-Sharafabad Fatemeh, Sahebkar Amirhossein, ... Maleki Vahid. The impact of resveratrol on toxicity and related complications of advanced glycation end products: A systematic review. Biofactors. 2019-Sep;45(5):651-665. doi:10.1002/biof.1531

Abstract

Accumulation of advanced glycation end products (AGEs) promotes the generation of free radicals, which leads to chronic oxidative stress predisposing to chronic oxidative stress, inflammation, and related diseases. This systematic review aimed to determine the effect of resveratrol (RSV) on AGE-induced toxicity and its deleterious consequences. A comprehensive search was performed through literature were published until December 2018 using relevant keywords. The databases that were used for the search were PubMed, Scopus, Embase, ProQuest, and Google Scholar. A total of 29 eligible studies were found and included in the review for the analysis. Except one, all studies showed suppressing effects for RSV on the production of AGEs or receptor for advanced glycation end products (RAGE) and its detrimental consequences including oxidative stress, inflammatory response, cellular immune reactions, insulin response, and atherosclerosis. RSV exerts its effects through influencing RAGE, nuclear factor kappa B (NF-κB), peroxisome proliferator-activated receptor (PPAR) γ, and transforming growth factor (TGF)-β activities. This review suggests that RSV has got potential to decrease AGEs toxicity and inhibit the AGE-induced complications. More clinical trials are suggested to evaluate the beneficial effect of RSV on AGEs in chronic metabolic diseases.

Key Findings

More clinical trials are suggested to evaluate the beneficial effect of RSV on AGEs in chronic metabolic diseases.

Outcomes Measured

  • inflammatory markers

Population

Field Value
Population See abstract
Sample Size See abstract
Age Range See abstract
Condition stress

MeSH Terms

  • Animals
  • Antigens, Neoplasm
  • Antioxidants
  • Atherosclerosis
  • Diabetes Mellitus, Experimental
  • Gene Expression Regulation
  • Glycation End Products, Advanced
  • Humans
  • Inflammation
  • Mitogen-Activated Protein Kinases
  • NF-kappa B
  • Oxidative Stress
  • PPAR gamma
  • Pyruvaldehyde
  • Resveratrol
  • Signal Transduction
  • Transforming Growth Factor beta1

Evidence Classification

  • Level: Systematic Review
  • Publication Types: Journal Article, Systematic Review
  • Vertical: resveratrol

Provenance

Source extracted via PubMed E-utilities API on 2026-04-09